Marrone completes financial audit
The US biopesticide company, Marrone Bio Innovations (MBI- Davis, California), is evaluating the need to refile certain financial reports with the Nasdaq stock exchange following the substantial completion of an internal investigation into financial irregularities. MBI submitted a plan on January 16th to regain compliance with the Nasdaq's continued listing and has been granted an extension until May 13th to file any delinquent reports and regain compliance. The Nasdaq ordered the company to submit the plan after it failed to submit its financial results for the third quarter of 2014. The company was investigating an $870,000 transaction in the fourth quarter of 2013.